PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · IEX Real-Time Price · USD
1.615
+0.035 (2.22%)
Jun 21, 2024, 4:00 PM EDT - Market closed

PMV Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Selling, General & Admin
24.2525.0521.811.015.88
Upgrade
Research & Development
55.8951.9936.4923.9320.76
Upgrade
Operating Expenses
80.1377.0458.2934.9426.64
Upgrade
Operating Income
-80.13-77.04-58.29-34.94-26.64
Upgrade
Other Expense / Income
-11.17-3.71-0.47-0.51-1.29
Upgrade
Pretax Income
-68.96-73.33-57.82-34.43-25.34
Upgrade
Income Tax
0-0.010.020.010.01
Upgrade
Net Income
-68.96-73.32-57.85-34.44-25.35
Upgrade
Shares Outstanding (Basic)
484645143
Upgrade
Shares Outstanding (Diluted)
484645143
Upgrade
Shares Change
5.31%1.01%214.23%373.26%0.76%
Upgrade
EPS (Basic)
-1.44-1.61-1.28-2.40-8.35
Upgrade
EPS (Diluted)
-1.44-1.61-1.28-2.40-8.35
Upgrade
Free Cash Flow
-56.62-71.74-47.92-32.89-22.17
Upgrade
Free Cash Flow Per Share
-1.18-1.57-1.06-2.29-7.31
Upgrade
EBITDA
-68.07-72.68-56.54-34.12-24.96
Upgrade
Depreciation & Amortization
0.890.651.280.320.39
Upgrade
EBIT
-68.96-73.33-57.82-34.43-25.34
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).